tiprankstipranks
Trending News
More News >
Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
US Market

Iterum Therapeutics (ITRM) Income Statement

Compare
930 Followers

Iterum Therapeutics Income Statement

Last quarter (Q3 2025), Iterum Therapeutics's total revenue was $390.00K, an increase of Infinity% from the same quarter last year. In Q3, Iterum Therapeutics's net income was $-8.98M. See Iterum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -254.00K$ -1.75M$ -1.80M$ -2.10M$ -161.00K
Operating Expenses
$ 18.44M$ 45.72M$ 28.58M$ 22.43M$ 31.96M
Depreciation and Amortization
$ 284.00K$ 1.75M$ 1.80M$ 2.10M$ 161.00K
EBITDA
$ -21.73M$ -34.58M$ -39.97M$ -83.20M$ -36.01M
Operating Income
$ -18.70M$ -47.47M$ -30.38M$ -24.54M$ -32.13M
Other Income/Expenses
$ -5.84M$ 9.71M$ -13.75M$ -66.32M$ -19.14M
Pretax Income
$ -24.53M$ -37.76M$ -44.13M$ -90.86M$ -51.26M
Net Income
$ -24.77M$ -38.37M$ -44.43M$ -91.56M$ -52.01M
Per Share Metrics
Basic EPS
$ -1.26$ -2.96$ -3.63$ -8.41$ -32.49
Diluted EPS
$ -1.26$ -2.96$ -3.63$ -8.41$ -32.49
Weighted Average Shares Outstanding
19.70M 12.96M 12.24M 10.89M 24.01M
Weighted Average Shares Outstanding (Diluted)
19.70M 12.96M 12.24M 10.89M 24.01M
Currency in USD

Iterum Therapeutics Earnings and Revenue History